Home / Petrochemicals / Meniere Disease Global Clinical Trials Review, H2, 2017

Meniere Disease Global Clinical Trials Review, H2, 2017

Published: Dec 2017 | No Of Pages: 61 | Published By: GlobalData

GlobalData's clinical trial report, “Meniere Disease Global Clinical Trials Review, H2, 2017" provides an overview of Meniere Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Meniere Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Otonomy Inc

Sound Pharmaceuticals Inc

Orifarm Group A/S

Lambda Therapeutic Research Ltd

Cromsource Srl

Buffalo ENT Specialists LLP

Auris Medical Holding AG

Alvogen Inc

AbbVie Inc

Abbott Laboratories

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Clinical Trials by G7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 19

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Meniere Disease Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Meniere Disease 34

Nov 08, 2017: Otonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX in Patients with Ménière's Disease 34

Oct 03, 2017: Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Menieres Disease 34

Clinical Trial Profile Snapshots 35

Appendix 57

Abbreviations 57

Definitions 57

Research Methodology 58

Secondary Research 58

About GlobalData 59

Contact Us 59

Source 60

Meniere Disease Therapeutics, Global, Clinical Trials by Region, 2017* 8

Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12

Meniere Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13

Meniere Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 14

Meniere Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 16

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 20

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Meniere Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 24

Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25

Meniere Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27

Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28

Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29

Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30

Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32

Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

Meniere Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 8

Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12

Meniere Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13

Meniere Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2017* 16

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2017* 20

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Meniere Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24

Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25

Meniere Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27

Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28

Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29

Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30

Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32

Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

GlobalData Methodology 59

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +